5th Pharmacovigilance Congregation 2013
"Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management" 20th November 2013, Kohinoor Continental Hotel, Mumbai, India.
- (1888PressRelease) November 20, 2013 - KEY THEMES DISCUSSED IN THIS CONFERENCE:-
• Exploiting the latest technologies, methodologies & automations on work practices of Pharmacovigilance
• Keeping abreast of the changes impacting the drug safety industry to ensure the pharmacovigilance strategies are robust and geared to compliance
• Recent successful strategies and business models to bring out new medicines
• How will PV activities change with Clinical Trial Transformation Initiative?
• Identifying essential antidote requirements and learn to implement best practices in drug safety and surveillance
• Exploiting the pharmacy automations and technologies for enhancement of medication safety
• Stay ahead of computing and electronic communications in pharmacovigilance
• Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
• Establishing the importance of pharmacovigilance for the safety of the patient
• Determining the steps and strategies for enhancing quality in healthcare
• Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
• Analyzing the information on current industry projects and trends
• Identifying the latest regulatory framework for pharmacovigilance
• Global marketing strategies in order to engage with regulatory centres of excellence on pharmacovigilance
• Accelerating new medicine introduction in developing world & overcoming challenges
• Explaining how to use the data sources and observational research for effective safety analysis
• Good supply chain management practices for medicine distribution
• Be part of a major networking opportunity
KEY SPEAKERS:-
• Deepa Arora, Global Head, Drug Safety & Risk Management, Lupin
• Arun Bhatt, President, Clininvent Research
• Moin Don, Executive Director, PVCON Pharmacovigilance Auditing & Consulting Services & Head Pharmacovigilance, Reliance Clinical Research
Services
• Bhaswat Chakraborty, Senior Vice President, Research & Development, Cadila Pharmaceuticals
• Parminder Kaur, Owner & Regulatory Affairs & PhV Consultant (QPPV), RegPak BioPharma Consulting (Netherlands, UK)
• Babita Kirodian, Head - Pharmacovigilance, Bristol-Myers Squibb
• Rajani Rokade, Head - Pharmacovigilance, Sanofi Aventis
• Veena Rajan, Head - Patient Safety, AstraZeneca
• Sofi Joseph, Head - Regulatory Operations, Pfizer
• Manish Mistry, Medical Director, Novartis
• Abhay Chimankar, Global Safety Officer, Cipla
• Girish Parhate, Senior Manager - Regulatory Affairs, Bayer
• Indu Nambiar, Clinical Safety Officer, Boehringer Ingelheim
• Prashant Bodhe, Director, CliniSearch
• Deepti Sanghavi, Senior Medical Writer - Medical Writing, SIRO Clinpharm
• Milind Antani, Head - Pharma LifeSciences group, Nishith Desai Associates
• Anish Desai, Director Medical Affairs and Clinical Operations, Johnson & Johnson
Plus Many More....
WHO SHOULD ATTEND:-
Vice Presidents, Directors, CRO's, Heads and Managers of:
• Pharmacovigilance Strategy
• Drug Safety/Risk Management
• Information and Clinical Data Management
• Clinical Research
• Research & Development
• Product Safety/Assurance Assessment
• Patient Safety & Outcomes Research & Data Analysis
• Epidemiology project management
• Regulatory Affairs and Compliance
• Sales & Marketing
• Biotech manufacturers
WHY SHOULD YOU ATTEND:-
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
CONFERENCE BOOKING DETAILS:-
Early Bird Discounted Price - Conference Delegate Pass (INR 4,000 + Tax (12.36%) per delegate) - Book and Pay before 07th October 2013 to avail the early bird discounted price. You can simply email or call and book your conference delegate seats on TEL: + 91 44 65150714. Email - nisha @ virtueinsight . com
Standard Price After Early Bird Discounted Time - 1 or 2 Delegates (INR 5,000 + Tax (12.36%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: + 91 44 65150714. Email - nisha @ virtueinsight . com
Group Discounts - 3 and above Delegates - (INR 4,000 + Tax (12.36%) per delegate)
Spot Registration on the day of the Conference - 1 Day Conference - (INR 6,000 + Tax (12.36%) per delegate)
Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to - TEL: + 91 44 65150714. Email - nisha @ virtueinsight . com
For more info on the event and for event brochure kindly visit -
http://www.virtueinsight.com/pharma/5th-Pharmacovigilance-Congregation-2013/
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam